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1. Introduction
1.1 Purines
1.1.1 Structure and function of purines
A purine is a heterocyclic compound which consists of a pyrimidine and an imidazole
ring (Figure 1.1). Purines play significant roles in the genetic and metabolic processes of all
living organisms. The purine bases, adenine and guanine (shown in Figure 1.1) are
fundamental components of nucleotides, which are the building blocks of DNA and RNA.
Purines are also crucial components of many other biomolecules such as the energy storage
molecule ATP, signaling molecule cAMP and the cofactor NADH.

Figure 1.1 Structures of purine, adenine, guanine, ATP, cAMP and NADH.
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1.1.2 Purine biosynthesis pathways
Given the critical roles played by purines, two pathways exist for their synthesis. Purines
can be synthesized either by the de novo pathway or the salvage pathway.
The salvage pathway for purine synthesis is a recycling biochemical pathway in which
the purine heterocycles created from the degradation of complex biomolecules, such as
DNA, are reused to synthesize new purine nucleotides.1 Phosphoribosyltransferases are
criticial salvage pathway enzymes which catalyze the reaction between the bases and PRPP
(Scheme 1.1).2 In animals, this pathway is important for some cells which lack the enzymes
required in the de novo pathway, such as the red blood cell.3

Scheme 1.1 Salvage pathway of purine biosynthesis.
De novo is a Latin phase meaning “from the beginning”. De novo biosynthesis refers to
the process of complex molecule synthesis from simple starting materials. The de novo
purine pathway begins with PRPP (shown in Figure 1.2). Glutamine donates an amino
group to PRPP at C-1 to yield PRA. This reaction is catalyzed by the enzyme, PurF. In the
next step glycine is added to generate GAR. After a formylation reaction, GAR is
converted into FGAR. In the following step, glutamine provides the source of nitrogen to
generate FGAM. Dehydration and ring closure

3

Figure 1.2 De novo purine biosynthesis pathway.
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yields AIR. AIR is ultimately converted into CAIR by processes which differ depending on
the organisms. Aspartic acid is then added to CAIR to yield SAICAR. In the following step,
SAICAR is converted to AICAR, which is formylated and cyclized to yield IMP, which is
the first ribonucleotide containing a purine ring. IMP is then converted to GMP and AMP
to give the basic purine nucleotides.
In general, purine synthesis is mostly conserved in all living organisms.4 The only
known divergence in de novo purine biosynthesis occurs between microorganisms and
higher eukaryotes.5 The difference occurs in the sixth step of the pathway (shown in figure
1.3). In bacteria, fungi and yeast, AIR is converted into CAIR via the intermediate
N5-CAIR. Two enzymes are required, namely N5-CAIR synthetase and N5-CAIR mutase.6
The enzymes are also frequently referred to as PurK and Class I PurE respectively. PurK
converts AIR, ATP and bicarbonate to N5-CAIR, ADP and Pi. Class I PurE transfers the
carboxyl group of N5-CAIR from N-5 to C-4 of the aminoimidazole ring. In higher
eukaryotes, AIR is directly converted to CAIR in one step by the enzyme AIR carboxylase.
AIR carboxylase is designated as a Class II PurE. Class II PurEs utilize carbon dioxide as
the source of the carboxyl group.7
The divergence of the de novo purine biosynthesis pathways between microorganism and
human suggests that the sixth step may be a good antimicrobial target. Inhibitors of Class I
PurE and PurK are currently being studied as antimicrobial agents.8
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Figure 1.3 Divergence at the sixth step of purine synthesis in human and microorganisms. R
is ribose 5’-phosphate.
1.1.3 Structure and function of PurK and PurE
The crystal structures of both PurK and PurE from various organisms have been
published (Figure 1.4).9,10,11,12 PurK is a functional dimer6 which belongs to the ATP grasp
superfamily of enzymes.10 A single subunit of PurK contains three domains which are
named the A, B and C domains.10 The A domain contains the AIR binding site. Conserved
residues in the B and C domains are responsible for the binding of ATP. In functional
studies, PurK catalyzes the activation of bicarbonate by ATP to yield carboxyphosphate.
Then the amino group of AIR attacks either CO2 generated from carboxyphosphate or
carboxyphosphate itself to give N5-CAIR.6
Both Class I and Class II PurEs have been studied. The crystal structures of PurEs from
a variety of organisms have been determined.9,11,13 PurE is an octamer
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(a)

(b)

(c)

Figure 1.4 Crystal structures of (a) PurE (octomer), (b) PurE (monomer) and (c) PurK
(monomer) from E. coli.

composed of eight identical subunits.9,13 Class II PurEs, which are designated as
AIR carboxylases, catalyze direct conversion of AIR into CAIR. In some organisms, such
as the yeast Cryptococcus neoformans, a bifunctional enzyme containing both PurK and
PurE activity is created.14 In higher eukaryotes, like humans, the enzyme is also a
bifunctional protein containing AIR carboxylase (Class II PurE) and SAICAR synthetase
(PurC).15

In

humans,

this

bifunctional

enzyme

is

called

PAICS
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(phosphoribosylaminoimidazole

carboxylase/phosphoribosylaminoimidazole

succinocarboxamide synthetase). Sequence alignments between Class I and Class II PurEs
show that these enzymes are evolutionarily related to each other. However, biochemical
studies have shown the Class I and Class II PurEs are specific for their own reaction.14
1.1.4 Instability of N5-CAIR
N5-CAIR was an unknown intermediate in de novo purine biosynthesis until its discovery
in the 1990’s, some 40 years after most of the pathway was elucidated.6 One reason for this
is the fact that N5-CAIR is a primary carbamate and thus unstable (shown in Scheme 1.2).
N5-CAIR has a t1/2 of ~1 min at 30°C and pH 7.8 and it is nonenzymatically converted back
to AIR.15 The t1/2 of N5-CAIR varies depending upon pH and temperatures. The stability of
N5-CAIR decreases with decreasing pH and increasing temperature.15 The t1/2 at pH 8.4 is
~12 min, but at pH 7.6 is ~3 min.6 At 5°C the t1/2 is ~33 min. N5-CAIR can also be produced
from AIR nonenzymatically.16 AIR and 1 M HCO3- produce N5-CAIR so rapidly that it is
difficult to monitor. The amount of N5-CAIR generated from AIR and HCO3- is proportional
to the concentration of HCO3-. In the presence of 1 M HCO3-, 75% of AIR is converted

Scheme 1.2 Instability of N5-CAIR.
to N5-CAIR.16
The instability of N5-CAIR creates a significant challenge for the purine biosynthetic
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pathway. If the production of N5-CAIR is not regulated relative to its conversion to CAIR,
ATP utilization can rapidly become non-stoichiometric. A key, unresolved question is how
N5-CAIR synthesis and utilization are regulated. One method to study this is to investigate
the system under conditions in which N5-CAIR stability is limited. Given the fact that
N5-CAIR is unstable at higher temperatures, studying N5-CAIR synthesis with thermophilic
proteins could provide insight into the problem.

1.2 Thermotoga maritima
1.2.1 Discovery and features of T. maritima
T. maritima is a non-spore forming, rod-shaped Gram-negative bacterium, which was
originally isolated from geothermal heated marine sediments at Vulcano, Italy, and the
Azores.17 This extremely thermophilic bacterium grows between 80°C and 105°C, with an
optimal growth temperature of 80°C.17
The genome of T. maritima has been sequenced.18 Both purE and purK genes, which are
designated TM0446 and TM0447 individually, have been found in the genome sequence.
This suggests that T. maritima follows the de novo purine biosynthetic pathway commonly
found in microorganisms. Such a result may be unexpected given the instability of N 5-CAIR
noted above.
1.2.2 Purine biosynthesis in T. maritima
The TM0446 and TM0447 genes of T. maritima encode for N5-carboxyaminoimidazole
ribonucleotide mutase (TM0446, PBD code 1O4V) and synthetase (TM0447, PBD code
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3AX6) respectively.
The crystal structure of PurE (TM0446) shows the protein is an octamer with an inner
channel (Figure 1.5). The closest structural homologue of TM0446 protein is PurE from E.
coli. The residues at the active site are the same between these two PurEs. The similarity
between TM0446 and E. coli PurE in both gene sequence and protein structure indicates that
TM0446 may have the same catalytic activity as the standard Class I PurEs previous
studied.
The structure of TM0447 was studied as well (Figure 1.5).8 It is a dimer and contains an
ATP-grasp domain, indicating that TM0447 also belongs to the same superfamily as E. coli
PurK. This provides a hint that TM0447 may have the same function as PurK from E. coli.
While the crystal structures of these proteins have been reported, no biochemical studies
on these proteins have been published. Thus, while the available information suggests that
these proteins have the same activity as bacterial enzymes, no verification of this has been
presented.

10

(a)

(b)

(c)

(d)

(e)

(f)

Figure 1.5 Crystal structures of PurE and PurK from E. coli and T. maritima. Monomer of
PurE from E. coli (a) and T. maritima (b), monomer of PurE from E. coli (c) and T. maritima
(d), and monomer of PurK from E. coli (e) and T. maritima (f).
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1.3 Hypotheses
N5-CAIR is so unstable that it is readily converted back into AIR even under standard
biochemical conditions. Under severe conditions, such as high temperature, the utilization of
N5-CAIR is more troubling. The estimated t1/2 at 80°C is about 80 ms. The conversion of
AIR into N5-CAIR consumes ATP. If the production of N5-CAIR is not regulated relative to
its conversion to CAIR, ATP utilization can rapidly become non-stoichiometric. ATP is the
"molecular unit of currency" of intracellular energy transfer. If more ATP molecules are
consumed in conversion of AIR to CAIR because of the chemical instability of N5-CAIR,
this would be a wasteful expense for purine synthesis. Therefore, we are interested in how
bacteria deal with this problem. One mechanism to study this issue is to investigate how the
problem is dealt with under conditions in which N5-CAIR is even more unstable. Here we
study the functions of enzymes PurK and PurE from T. maritima, a thermophilic bacterium,
to try to understand how these two enzymes work to control N5-CAIR synthesis and
utilization at elevated temperatures.
Two hypotheses are proposed. One hypothesis assumes that there is a protein-protein
interaction between PurK and PurE which allows for either direct transfer of N5-CAIR from
PurK to PurE or for the regulation of N5-CAIR synthesis. The other one assumes PurE is
highly efficient and thus able to convert N5-CAIR to CAIR before it can decompose to AIR.
In this thesis, we will investigate the catalytic activities of both enzymes and examine the
synthesis and utilization of N5-CAIR at elevated temperature and in the combination of the
two proteins.
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2. Materials and Methods
2.1 Gene cloning
2.1.1 PCR for purE and purK
T. maritima PurE and PurK genes were cloned from genomic DNA from strain MSB8
(ATCC 43589) by PCR. Each reaction mixture of a final volume of 50 µL contained 1 µM
forward primer, 1 µM reverse primer, 1 µg template DNA, 1X Tag buffer, 1.25 U Taq,
1.5-4.0 mM MgCl2 and 0.2 mM dNTP mix. Primers were synthesized commercially
(Integrated DNA Technologies) (Table 2.1). The PCR was conducted for 30 cycles with each
cycle including denaturation at 95 °C (1 min), annealing at 55 °C (1 min) and extention at
74 °C (1 min). Products were purified by agarose gel electrophoresis and isolated from gel
slices using a genomic DNA purification kit (Promega).
Table 2.1 Sequences of primers for PCR.
genes

forward primers

reverse primers

purE (stop)

5’-AAACATATGCCAAGGGTAGGAATCATCA

5’-TTGCGGCCGCTTACTCTTTCTGGTTCAGA

purE (non-stop)

5’-AAACATATGCCAAGGGTAGGAATCATCA

5’-TTGCGGCCGCTGCCTCTTTCTGGTTCAGA

purK (stop)

5’-AAACATATGAAAAAGATCGGTATCATCG

5’-AAGCGGCCGCCTACCCTTGGCACATCGC

purK (non-stop)

5’-AAACATATGAAAAAGATCGGTATCATCG

5’-AAGCGGCCGCCATCCCTTGGCACATCGC

Underlined sequences are restriction sites: NdeI in forward primers and NotI in reverse primers.

2.1.2 Preparation of recombinant plasmids.
The purified purE and purK genes, which contained an A-tail, were ligated for 1 hr at
room temperature into the pGEM-T vector (Promega) using T4 DNA ligase (Promega).
Recombinant plasmids were transformed into E. coli DH5α and plated onto LB/X-gal for
use in blue-white screening. Blue colonies were grown in LB medium with 100 µg/mL
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ampicillin and plasmids were isolated by use of the Miniprep kit (Promega). The correct
plasmid was verified by restriction digests using NotI and NdeI (BioLabs).
The pGEM plasmids, pET-22b(+) and pET-28a(+) vectors (Novagen) were digested with
NotI and NdeI at 37 °C for one hour. The digested genes and plasmids were purified by
agarose gel electrophoresis and the genes were ligated into the plasmids. The genes ligated
into pET-22b(+) vector generated C-terminal His-tagged proteins. The genes ligated into
pET-28a(+) vector yielded N-terminal His-tagged proteins. Successful ligation was validated
by restriction digest with NotI and NdeI. Plasmids were amplified and sequenced by the
Applied Genomic Technology Center (Wayne State University) with T7 forward and T7
reverse primers. Sequence analysis gave the expected products with no mutations.
Expressed proteins will have the following additional sequences: HHHHHHSSGLVPRGSH
at the N-terminus or AAALEHHHHHH at the C-terminus.
2.2 Protein expression and purification
Bacteria with recombinant pET plasmids were incubated overnight in 5 mL of LB media
at 37 °C in the presence of 100 μg/mL ampicillin (pET-22 vectors) or 100 μg/mL kanamycin
(pET-28 vectors). The overnight culture was used to inoculate to 500 mL of LB medium
containing the corresponding antibiotics. The culture was incubated at 37 °C until an OD600
of 0.4 was obtained. IPTG (1 mM) was added to the medium and the incubation was
continued for 4 hours. Bacteria were collected by centrifugation at 4000 rpm, and stored at
-80 °C until use.
For protein purification, bacteria were lysed using the B-PER protein extraction reagent
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(Thermo). The weight of bacteria pellet was determined by a balance and 4 mL B-PER
reagent was added for per gram of cell pellet. The suspension was incubated for 10 min at
room temperature followed by centrifugation at 4 °C at 13,000 rpm. The supernatant was
treated with streptomycin sulfate to a final concentration of 1% and again centrifuged at
4 °C at 13,000 rpm to remove nucleic acids.
Protein purification was conducted at 4 °C. A 5 mL cobalt resin column (Gold Biotech)
was washed with 3 mL water and 3 mL of 10 mM imidazole buffer (containing 50 mM
sodium phosphate, 300 mM NaCl, pH 7.4) 3 times before the supernatant prepared above
was applied to the column. The column was washed with 3 x 3 mL of 10 mM, 25 mM, 150
mM and 400 mM imidazole containing buffer (50 mM sodium phosphate, 300 mM sodium
chloride, pH 7.4). Fractions were collected and analyzed by 12% SDS-PAGE using
Coomassie blue staining, which showed fractions containing 150mM and 400mM imidazole
possessed pure protein. Fractions contained pure protein were collected and concentrated by
dialysis centrifugal concentration (EMD). The protein was dissolved in buffer (containing 1
mM Tris-HCl and 50 mM NaCl, pH 8.0) and concentrated several times to remove
imidazole. The concentration of the protein was determined by Bradford assay using BSA as
a standard. The concentrations of PurEs and PurKs ranged from 1.5 mg/mL to 14 mg/mL.
Proteins were stored in 5 µL aliquots at -80°C.
2.3 Thermal stability of PurE and PurK from thermophilic bacteria
Melting points of PurEs and PurKs from both E.coli and T. maritima were measured
using a real-time PCR instrument (Stratagene Mx3005p, Agilent). Reactions in a final
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volume of 20 µL contained 150 mM NaCl, 10 mM HEPES buffer (pH 8.0), SYPRO Orange
and 75 µg/mL of protein. For PurE and PurK from T. maritima, melting studies were also
conducted with 500 mM guanidine in 10 mM HEPES buffer (pH 5.0 or 8.0). Fluorescence
of SYPRO Orange (Ex 492 nm and Em 610 nm) was determined as a function of
temperature from 25 °C to 95 °C. Melting curves were plotted as temperature vs.
fluorescence. Tm is determined by denaturation midpoint.
2.4 Stability of N5-CAIR
The equilibrium of AIR to N5-CAIR was determined from 20 °C to 80 °C using the
Varian UV-vis Cary 100 spectrophotometer. The equilibrium was determined in a total
volume of 1000 µL containing 250 mM NaPO4 buffer (pH 8.0) with 200 mM sodium
bicarbonate and 100 μM AIR. The mixture was added to a stoppered cuvette and was
preincubated at 20 °C for 15 min. The equilibrium was monitored at 260nm as the
temperature was ramped from 20 °C to 80 °C at a rate of 1 °C/min. The concentration of
N5-CAIR was calculated using the extinction coefficient of 970 M-1cm-1.20
2.5 Enzyme kinetics assay
Enzyme assays were conducted using the Cary 100 spectrophotometer equipped with a
temperature controller.
2.5.1 The activity of PurE and PurK
2.5.1.1 CAIR decarboxylation assay for PurE from E. coli and T. maritima
The assay for PurE was conducted in a total volume of 1000 µL containing 100 mM
Tris-HCl buffer (pH 8.0) and PurE (10 ng) from E. coli or PurE (450 ng for 21 °C, and
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200ng for both 37 °C and 50 °C) from T. maritima. The cuvette was incubated at 21, 37 or
50 °C for 2 min, and the reaction was initiated by addition of CAIR (12.5 - 200 µM). The
conversion of CAIR was monitored at 260 nm (Δε=8930 M-1cm-1).
2.5.1.2 AIR carboxylation assay for PurK from T. maritima
The assay was conducted in a final volume of 1000 µL containing 50 mM HEPES buffer
(pH7.8), 20 mM KCl, 6.0 mM MgCl2, 1.1 mM ATP, 2.0 mM PEP, 0.2 mM NADH, 1 mM
NaHCO3, 5 units of pyruvate kinase, 5 units of lactate dehydrogenase and PurK (500 ng).
The cuvette was incubated at 37°C or 50°C for 2 min prior to the initiation of the reaction by
addition of AIR (12.5-200 µM). The reaction was monitored by change in absorbance at 340
nm. The concentration of AIR consumed was calculated using the extinction coefficient of
6200 M-1cm-1.
2.5.1.3 Michaelis-Menten kinetics
The initial velocity vs concentration of substrate was plotted to generate a
Michaelis-Menten plot. The steady-state kinetic parameters of the enzymes were obtained
by non-liner regression of the plot to the Michaelis-Menten equation (1). Errors reported are
those obtained from curve fitting.

𝑣=

𝑣𝑚𝑎𝑥 [𝑆]
𝐾𝑚 +[𝑆]

(1)
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2.5.2 Assays of PurE and PurK in the presence of the other protein for PurE-PurK from T.
maritima
2.5.2.1 CAIR decarboxylation assay for PurE in the presence of PurK
The assay was conduted in a total volume of 1000 µL containing 100 mM Tris-HCl (pH
8.0), PurE (100 ng) and PurK (the molar ratios of PurK/PurE monomer were 0, 0.25, 0.5, 1
and 2). The mixture was incubated at 37°C or 50°C for 2 min and initiated by addition of
100 µM CAIR. The reaction was monitored by change in absorbance at 260 nm.
2.5.2.2 AIR carboxylation assay for PurK-PurE
The assay was conducted in a final volume of 1000 µL containing 50 mM HEPES buffer
(pH 7.8), 20 mM KCl, 6.0 mM MgCl2, 1.1 mM ATP, 2.0 mM PEP, 0.2 mM NADH, 1 mM
NaHCO3, 5 units of pyruvate kinase, 5 units of lactate dehydrogenase, PurK (500 ng) and
PurK (the molar ratios of PurK/PurE monomer are 0, 0.25, 0.5, 1 and 2). The cuvette with
the mixture was incubated at 37°C or 50°C for 2 min prior to initiation by addition of 100
µM AIR. The reaction was monitored by change in absorbance at 340 nm.
2.5.3 Activity of PurC from E. coli
PurC (E. coli) was the kind gift of Dr. Kappock (Purdue University). The activity of PurC
was determined by coupled assay monitoring ATP consumption and SAICAR production. In
the ATP consumption assay, the assay mixture contained the following in a final volume of
1000 µL: 50 mM HEPES buffer (pH 7.8), 20 mM KCl, 6.0 mM MgCl2, 1.1 mM ATP, 2.0
mM PEP, 0.2 mM NADH, 5 units of pyruvate kinase, 5 units of lactate dehydrogenase, 0.1
mM CAIR and PurC (50, 75, 100 and 125 ng). The cuvette with the mixture was
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preincubated at 37°C prior to initiation by addition of 10 mM aspartic acid. The reaction
was monitored by change in absorbance at 340 nm (Δε=6200 M-1cm-1). In the SAICAR
production assay, the reaction contained the following in a final volume of 1000 µL: 50 mM
HEPES buffer (pH 7.8), 20 mM KCl, 6.0 mM MgCl2, 0.1 mM ATP, 2.0 mM PEP, 5 units of
pyruvate kinase, 5 units of lactate dehydrogenase, 0.1 mM CAIR and PurC (50 ng, 75 ng,
100 ng and 125 ng). The reaction was monitored by change in absorbance at 282 nm
(Δε=8480 M-1cm-1).
2.5.4 N5-CAIR is the substrate for PurE
In the PurC coupled assay, SAICAR production was monitored to determine the substrate
of PurE (T. maritima). In the assay mixture of 1000 µL total volume, 50 mM HEPES buffer
(pH7.8), 20mM KCl, 6.0mM MgCl2, 0.1 mM ATP, 2.0mM PEP, 5 units of pyruvate kinase,
5 units of lactate dehydrogenase, 0.1 mM AIR, 200 ng PurE and 800ng PurC were included.
In another reaction, 700 ng PurK was also added to the same reaction mixture described
above. The mixture was preincubated at 37°C prior to initiation by addition of 10 mM
aspartic acid. These reactions were monitored at 282 nm.
2.5.5 Stoichiometry assay
The amounts of enzymes were calculated according to their specific activity so that the
reaction could be completed rapidly. The reaction mixture in a total volume of 1000 µL
contained the following: 50 mM HEPES buffer (pH7.8), 20 mM KCl, 6.0 mM MgCl2, 0.1
mM ATP, 2.0 mM PEP, 5 units of pyruvate kinase, 17.8 µM AIR, 1000 ng or 500 ng PurE,
2220 ng PurK and 1260 ng PurC. PurE and PurK were added in the molar ratios of 1:1 or
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1:2. The reactions were incubated at 37°C or 50°C and initiated by addition of 10 mM
aspartic acid. The reactions were monitored at 282 nm for SAICAR production and the
change in the absorbance was used to calculate the amount of SAICAR produced (Δε=8480
M-1cm-1). To determine the amount of ATP, the same assay as above was repeated expect 0.2
mM NADH was added and ATP level was increased to 1.1 mM. The reaction was monitored
at 340nm and the concentration of ATP was calculated from the change of absorbance
(Δε=6200 M-1cm-1).
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3. Results
3.1 Gene Cloning
Since both PurE and PurK from T. maritima had been crystalized, we initially
attempted to express the proteins from vectors used in these studies. We were unable to
obtain the PurK expression plasmid from the authors. For PurE, we obtained the
recombinant plasmid pMH1 containing the purE gene fused to a 6X His-tag. The plasmid
was transformed into E.coli LMG194 for protein expression induced by arabinose. Protein
expression studies with various concentration of arabinose in a variety of media failed to
generate PurE as determined by SDS-PAGE and a his-tag western blot. Attempted
purification by a cobalt column also failed to produce the desired protein.
Given these challenges, we elected to clone these genes ourselves. The purE and purK
genes were cloned from genomic DNA of T. maritima by PCR (Figure 3.1). For each gene,
we prepared two constructs. The first placed the his-tag on the N-terminus while the
second placed the tag on the C-terminus. PCR was conducted with different
concentrations of MgCl2 to determine the optimum concentration of magnesium. The
optimal concentration of MgCl2 was determined to be 1.5 mM.
The purified PCR products were ligated into the pGEM-T (Promega) vector for
amplification. Vectors containing the purE and purK inserts were determined by
restriction mapping (Figure 3.2). The purE and purK were removed from the vector
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Figure 3.1 PCR products: (a) purE without stop codon, (b) purE with stop codon, (c) purK
without stop codon and (d) purK with stop codon. M: molecular weight marker. 1-5: 1.5, 2.0,
2.5, 3.0 and 4.0 mM magnesium chloride.

Figure 3.2 Genes digested from recombinant pGEM-T vectors: (a) purE without stop codon,
(b) purE with stop codon, (c) purK without stop codon and (d) purK with stop codon. M
refers to standard DNA marker, 1-5 refers to plasmids isolated from different colonies.
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by NotI and NdeI, and the inserts were gel purified and ligated into either pET-22b(+) (for
C-terminal His-tagged proteins) or pET-28a(+) (for N-terminal His-tagged proteins) for
protein expression. The recombinant expression plasmids were verified by restriction
mapping (Figure 3.3) and DNA sequencing.

Figure 3.3 Recombinant pET plasmids were double digested by the NotI and NdeI
restriction enzymes to verify ligation of genes in pET vectors: (a) purE genes and (b) purK
genes. M refers to standard DNA marker, 1-4 refers to different plasmids isolated from
different colonies.

3.2 Protein expression and purification
The recombinant pET plasmids were transformed into BL21 DE3. A single colony was
incubated overnight at 37 °C in 5 mL LB medium in the presence of either ampicillin or
kanamycin. This was used to innoculate 500 mL of fresh LB medium containing ampicillin
or kanamycin and the culture was incubated until an OD400 of 0.4 was obtained. Bacteria
were incubated for 4 hours either in the absence or presence of 1 mM IPTG. Bacteria were
collected by centrifuging, and stored at -80 °C until use. For purification, the bacteria were
thawed and incubated with B-PER lysis buffer (Promega) before being applied to a 5 mL
cobalt resin column (Gold Biotech). The column was washed with phosphate buffer
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containing 10 mM imidazole followed by a step gradient of buffer containing 10, 25, 150
and 400 mM imidazole. Fractions were collected and analyzed for purity by SDS-PAGE.
Fractions containing pure protein were collected and concentrated. Imidazole was removed
by repeated dilution and concentration. Proteins were stored in 5 μl aliquots at -80 °C. The
purity of each protein was determined by SDS-PAGE and was judged to be at least 98%
pure (Figure 3.4)

Figure 3.4 SDS-PAGE analysis of pure protein: (a). PurE-His, (b). His-PurE, (c). PurK-His, (d).
His-PurK. M: protein ladder. 1-6: 0.5, 1, 2, 4, 8 and 10 µg proteins.
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3.3 Thermal stability of PurE and PurK from thermophilic bacteria.
The thermostability of PurEs from E. coli and T. maritima were measured using a thermal
shift assay. In this experiment, unfolded protein is detected by Sypro Orange, a fluorescent
dye that binds to exposed hydrophobic surfaces in the denatured protein. This results in an
increase in fluorescence as a function of protein unfolding. To promote unfolding, the
temperature is increased. A real-time PCR instrument was used to detect the thermal melting
of the protein. Melting curves of both PurEs are shown in Figure 3.5 a. The melting
temperature for PurE (E.coli) in 300 mM NaCl at pH 8.0 is 72 °C. In contrast, no change in
fluorescence intensity for PurE from T. maritima was observed under any conditions.
Changes in pH and the addition of denaturant also failed to give a measurable melting
temperature. These studies indicate that PurE from T. maritima is significantly more stable
than E. coli PurE.
The thermal stability of PurKs from E. coli and T. maritima were also measured using the
thermal shift assay (Figure 3.5 b). The melting temperature of PurK (E. coli) in 300 mM
NaCl at pH 8.0 is 68 °C. The changes of fluorescence intensity for PurK from T. maritima
under all conditions tested were similar with PurE (T. maritima). These results indicate that
the PurK from T. maritima is again remarkably more stable than E. coli PurK.
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Figure 3.5 (a). Melting curves of PurE (E. coli) and PurE (T. maritima) from 25 °C to
95 °C: A. PurE (E. coli) at pH 8, B. PurE (T. maritima) at pH 8, C. PurE (T. maritima) at pH
5, D. PurE (T. maritima) at pH 5 in the presence of 500 mM guanidine, E. PurE (T.
maritima) at pH 10, F. PurE (T. maritima) at pH 10 in the presence of 500 mM guanidine.
Data from one experiment only in shown for clarity.
(b). Melting curves of PurK (E. coli) and PurK (T. maritima) from 25 °C to 95 °C: G. PurK
(E. coli) at pH 8, H. PurK (T. maritima) at pH 8, I. PurK (T. maritima) at pH 5, J. PurK (T.
maritima) at pH 5 in the presence of 500 mM guanidine, K. PurK (T. maritima) at pH 10, L.
PurK (T. maritima) at pH 10 in the presence of 500 mM guanidine. Data from one
experiment only in shown for clarity.
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3.4 Enzyme kinetics
3.4.1 Activity of PurE and PurK from T. maritima.
Although both PurE and PurK from T. maritima had been crystallized, no studies on the
activity of these enzymes have been reported. Thus we conducted a full characterization of
these proteins. For PurE, we examined the activity of the reverse reaction, CAIR converted
to N5-CAIR, using the standard CAIR decarboxylation assay.6 This assay was chosen
because of the instability of N5-CAIR. For PurK, we utilized the AIR carboxylation assay.
We examined the activity of both the N and C-terminal His-tagged PurEs and PurKs at
various temperatures (Table 3.1). For PurK, we did not examine the kinetic constant of
bicarbonate because the equilibrium of this substrate is affected at different temperatures.
Both the C-terminal His-tagged PurE and PurK from T. maritima showed higher Vmax and
kcat at higher temperature, indicating that these enzymes prefer to operate at high
temperatures. However, the effect on Km of various substrates for PurE and PurK were
opposite. The increasing Km of CAIR for PurE at high temperature suggested that the
temperature affected substrate binding. In contrast, the Km of AIR for PurK decreased when
the temperature increased. The position of His-tag also affected the kcat and Km of PurE.
N-terminal His-tagged PurE showed a lower Km and kcat, but the efficiency was roughly
same with C-terminal His-tagged PurE. Comparing the kcat/Km value at different
temperatures indicated that there was no big difference among the efficiency of PurEs at
different temperatures, while PurK was more efficient as the temperature increased.
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Table 3.1 Steady-state kinetic constants for PurE and PurK
temp

Vmax

kcat
-1

Km

kcat/Km

enzyme

(°C)

substrate

(µmol/min·mg)

(min )

(µM)

(min-1M-1)

PurE (E.coli)Ca

37

CAIR

270±17

38200±2500

30±6.7

1.3±0.31x109

PurE (E.coli)C

50

CAIR

240±7

34000±1000

11±1.8

3.2±0.79x109

PurE (T.maritima)C

21

CAIR

5.2±0.2

870±30

11±2.3

0.83±0.26x108

PurE (T.maritima)C

37

CAIR

18±2

2688±367

36±8.0

0.75±0.34x108

PurE (T.maritima)C

50

CAIR

38±6

5700±900

74±17

0.78±0.38x108

PurE (T.maritima)Cc

80

CAIR

69

10300

135

0.76x108

PurK(T.maritima)C

21

AIR

0.8±0.1

640±40

77±13

0.83±0.23x107

PurK (T.maritima)C

37

AIR

5.2±0.1

4400±60

19±1.6

2.4±0.83x108

PurK (T.maritima)C

50

AIR

11±1

9100±680

18±0.4

5.2±2.51x108

PurK (T.maritima)Cc

80

AIR

21

17800

18

1.2x109

PurK (T.maritima)C

37

ATP

2.2±0.1

3700±100

56±5.1

0.66±0.1x108

PurK (T.maritima)C

50

ATP

4.9±0.2

8350±390

84±11

1.0±0.20x108

PurE (T.maritima)Nb

21

CAIR

6.0±0.3

900±51

8.5±2.6

1.1±0.49x108

PurE (T.maritima)N

37

CAIR

13±0.3

1930±46

2.7±0.5

0.71±0.1x108

PurE (T.maritima)N

50

CAIR

25±1

3740±140

2.1±0.6

1.8±0.86x108

PurE (T.maritima)Nc

80

CAIR

43

6400

2.1

3.0x108

PurK (T.maritima)N

37

AIR

2.3±0.1

3800±82

23±1.9

1.7±0.19x108

PurK (T.maritima)N

37

ATP

2.7±0.2

4600±300

50±10

0.93±0.3x108

a. C terminus 6X His-tag. b. N terminus 6X His-tag. c. Constants at 80 °C are estimated.

T. maritima grows optimally at 80 °C. Attempts to investigate the activity of these
proteins above 60 °C proved challenging due to the instability of the substrates used in the
assay. To estimate the activity at 80 °C, we studied each enzyme at different temperatures. A
plot of activity vs temperature gave a straight line. Thus we can estimate the activity of the
enzymes at higher temperatures (Figure 3.6). The calculated Vmax of C-terminal His-tagged
PurE (T. maritima) at 80 °C is 69 µmol/min·mg, kcat is 10,300 min-1 and Km is 135 µM. The
estimated value of kcat/Km
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Figure 3.6 Relationship between activity of enzymes (T. maritima) and temperature. (a)
Vmax of PurE (T. maritima). (b) Km of PurE (T. maritima). (c) Vmax of PurK (T. maritima).
(d) Km of PurK (T. maritima).

29

for this PurE (T. maritima) at 80 °C is 0.76x108 min-1M-1. The estimated Vmax of C-terminal
His-tagged PurK (T. maritima) at 80 °C is 21 µmol/min·mg, and kcat is 17,800 min-1. There
is no linear relationship between Km and temperature for PurK. An examination of the data
suggests that the Km at 80 °C is likely the same as that at 50 °C. Therefore the estimated
value of kcat/Km for PurK (T. maritima) is 1.2x109 min-1M-1. These estimated values indicate
that both enzymes are highly efficient at 80 °C.
To determine whether AIR or N5-CAIR is the substrate of PurE, a coupled AIR
carboxylase assay (Scheme 3.1) was conducted with PurE (T. maritima) and PurC (E. coli)
in the absence or presence of PurK (T. maritima).

Scheme 3.1 Coupled AIR carboxylase assay with E. coli PurC.
SAICAR production in the presence of PurK (T. maritima) is greater than in the absence
of PurK (Figure 3.7). This indicates that PurK catalyzed AIR into N5-CAIR which is utilized
by PurE as a substrate. Therefore, as predicted, N5-CAIR is the substrate for PurE. Thus, the
PurK and PurE enzymes from T. maritima are functionally identical to these from E. coli.
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Figure 3.7 Change of absorbance at 282 nm (for SAICAR production) from AIR catalyzed
by PurE (T. maritima) and PurC (E. coli) in the presence and absence of PurK (T. maritima)
at 37 °C.
3.4.2 Stability of N5-CAIR
In the absence of enzymes, AIR and bicarbonate can be nonenzymatically converted into
N5-CAIR in minutes or CAIR after more than 70 hours.16 To study the conversion of AIR
into N5-CAIR at different temperatures, we conducted a thermal assay that monitored
N5-CAIR production at pH 8.0 from 20 °C to 80 °C (Figure 3.8). Previous studies indicated
that the AIR/ N5-CAIR equilibrium was rapidly reached and therefore we expect that the
value represents the equilibrium value for that temperature.16 N5-CAIR was monitored at
260 nm where the extinction coefficient of AIR (1570 M-1cm-1) is much higher than that of
N5-CAIR (710 M-1cm-1). We observed that the percentage of N5-CAIR decreased as the
temperature increased. This result is also consistent with previous studies which show that
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N5-CAIR is more unstable at higher temperatures.16 These studies validate that N5-CAIR is
highly unstable at 80 °C and the concentration of this intermediate in solution is very low.
At 80 °C, only 2% of AIR is converted into N5-CAIR. Thus, this intermediate must be

Concentration of N5-CAIR (µM)

carefully utilized and/or stabilized.
30
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Figure 3.8 Equilibrium of AIR/HCO3-/N5-CAIR as a function of temperature.
Data from one experiment only is shown for clarity.

3.4.3 Stoichiometry
A key question in these studies is whether at elevated temperature, the N5-CAIR that is
produced can be effectively utilized by the system before it is broken down to AIR. This
would lead to a non-stoichiometric consumption of ATP. To measure this, we examined the
stoichiometry of the PurK and PurE enzymes using the coupled PurC assay system (Table
3.2). We measured ATP consumption using the NADH coupled system and AIR
consumption by the production of SAICAR at 282 nm. In the stoichiometry assays, enough
enzymes were used to make sure AIR (17.8 μM) could be completely converted in several
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minutes.
Table 3.2 Stoichiometry assaya
Temp(°C)

Molar ratio of
PurE to PurK

AIR(µM)

ATP(µM)

SAICAR(µM)

37
50
50

1:1
1:1
1:2

17.9±0.7b
17.7±0.4
17.9±0.1

35.2±2.4
38.1±6.6
52.4±4.1

17.1±1.4
17.7±1.8
17.5±3.3

a. Each assay was done in triplicate. b. AIR concentration was determined at 250nm
(ε=3830 M-1cm-1, pH 7.0).

When the molar ratio (monomer) of PurE to PurK was 1:1, the reaction showed the
expected stoichiometry of 1:2:1 at 37 °C. Increasing the temperature to 50 °C gave the same
result. Decreasing the concentration of PurE lead to a non-stoichiometric consumption of
ATP, presumably because the nonenzymatic conversion of N5-CAIR to AIR was faster than
the conversion of N5-CAIR. This indicates that the ratio of PurE to PurK is critical for
preventing the waste of ATP at the expense of N5-CAIR synthesis.
3.4.4 Protein-protein interaction
One mechanism by which N5-CAIR could be stabilized is by binding to PurK until PurE
is available for catalysis. In addition, channeling between PurK and PurE could also occur.
To examine this, we determined the rate of each enzyme in the presence of the other protein.
Different monomer molar ratios (0.25, 0.5, 1 and 2) of these two proteins were mixed and
either the AIR carboxylation or CAIR decarboxylation assays were conducted (rates shown
in Figure 3.9).

(a)

Average rate (min-1)
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Figure 3.9 The average rate (triplicate) for CAIR decarboxylation assay at 37°C (a)
and 50°C (b), and AIR carboxylation assay at 37°C (c) and 50°C (d).
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In the CAIR decarboxylation reaction for PurE, PurK was added in the mixture without its
substrates, such as ATP and AIR. Therefore, PurK was inactive in this assay. The inactive
PurK decreased the activity of PurE by 21% at 37 °C and 29% at 50 °C. The result suggests
that PurK can regulate PurE; however, the mechanism by which this occurs is unknown.
Repeating this assay in the presence of BSA resulted in no change.
For PurK, we utilized the AIR carboxylation reaction with PurE added in different molar
ratios. In this assay, PurE was active since there was N5-CAIR produced by PurK. At 37 °C,
the activity of PurK increased by 11% in the presence of PurE. And again, BSA had no
change. This could suggest that the complex is formed. At 50 °C, the reaction showed the
opposite result, the PurK activity decreased. We believe that the reason for this result at
50 °C can be explained by the stoichiometry results. For the molar ratio of PurE to PurK at 0
or 1:2, the reaction is nonstoichiometric and consumes more ATP because the N5-CAIR is
decarboxylated back to AIR. As the amount of PurE increases, the N5-CAIR produced is
converted to the more stable CAIR and thus the rate of ATP consumption decreases.
The protein-protein interaction study shows that the PurE and PurK from T. maritima can
regulate each other. It suggests that these two enzymes probably form a protein complex.
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4. Discussion
4.1 Properties of PurE and PurK from T. maritima
The roles of PurK and PurE from E. coli have been studied by Meyer6 and Mueller16.
Sequence comparisons of T. maritima with E. coli have indicated that T. maritima purE and
purK genes are similar to those from E. coli, and the protein structure similarities with E.
coli PurE and PurK have also been noted.6,9,10,13,19 We have studied the substrate specificity
for PurK and PurE from T. maritima. T. maritima PurK was studied by the standard AIR
carboxylation assay, which indicated that this enzyme utilized the same substrates as the
enzyme from E. coli. Previous studies have shown that there are at least two classes of
PurEs: N5-CAIR mutase and AIR carboxylase. To investigate PurE from T. maritima, we
conducted a coupled assay with E. coli SAICAR synthetase in the absence or presence of
PurK from T. maritima. In the absence of PurK, SAICAR synthesis was minimal indicating
that T. maritima PurE was unable to catalyze the conversion of AIR into CAIR. However, in
the presence of PurK, SAICAR synthesis was robust revealing that N5-CAIR was the
substrate of T. maritima PurE. Both of these results indicate that T. maritima follows the
same pathway previously determined for E. coli.
By studying the functions of PurK and PurE from T. maritima, we have shown that these
enzymes have a functional similarity to the enzymes from E. coli. We have investigated the
activity of these enzymes at different temperatures and have shown that they have higher
activity at higher temperature. This is not surprising for an enzyme from a thermophilic
organism. Thermal studies for other enzymes from thermophilic organisms have been
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published.21,22 For example, in the study of S-adenosylhomocysteine hydrolase from T.
maritima, the enzyme was most active at 75 °C.22 The enzyme also showed thermostability
at 75 °C after incubating for 120 min. In another study, the thermostability of T. maritima
dihydrofolate reductase was investigated by incubating the enzyme at high temperatures for
15 min.21 The results showed that 100% of enzyme activity are retained at 75 °C while 65%
remained at 90 °C.
4.2 The problem with N5-CAIR
Our studies on PurK and PurE from T. maritima indicate that this organism follow the
same pathway for purine biosynthesis as E. coli. Such a result presents a potential problem.
N5-CAIR is an unstable intermediate. The t1/2 of N5-CAIR at 37 °C is 1.3 min.16 The
estimated t1/2 at 80 °C is about 80 ms. This rapid rate of decarboxylation suggests that
N5-CAIR may not be a viable intermediate in purine biosynthesis. However, it is instructive
to

look

at

other

unstable

carbamates

found

in

microbes.

The

compound

N-carboxymethanofuran is an intermediate in the methanogenesis pathway found in
methanogenic bacteria. A study of N-carboxymethanofuran shows that the t1/2 of this
primary carbamate is 1 s at 17 °C and 88 ms at 37 °C in solution of pH 8.0.23 Thus, this
critical compound is even more unstable than N5-CAIR, yet is still a key component is
methanogenesis.
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Figure 4.1 Structures of N5-CAIR and N-carboxymethanofuran.
R1=ribose 5’-phosphate. R2=4-[N-(4,5,7-tricarboxyheptanoyl-γ-L-glutamyl-γ-L-glutamyl)p-(β-aminoethyl) phenoxymethyl]
The instability of N5-CAIR presents a challenge for de novo purine biosynthesis in T.
maritima because ATP is consumed in the conversion of AIR to N5-CAIR. If N5-CAIR
decomposes back to AIR, more ATP will be consumed. Thus, under certain conditions, a
futile cycle can be created where the consumption of ATP is much greater than the synthesis
of IMP from the pathway.
In the study of the equilibrium of AIR and N5-CAIR, the results show that 30% of AIR is
converted into N5-CAIR at 37 °C, but only 2% at 80 °C. The equilibrium and kinetic data
clearly indicate that the amount of N5-CAIR present at 80 °C is low. Of course, the actual
level of N5-CAIR would be dependent upon the concentration of CO2 in the bacteria as well
as the temperature.
Despite the challenge with N5-CAIR, the stoichiometry data at 50 °C showed that the
reaction of AIR to SAICAR is stoichiometric with conditions in which the molar ratio of
PurE and PurK are equal. However, when PurE is less than PurK, the reaction is not
stoichiometric presumably due to the decomposition of N5-CAIR which leads to more ATP
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consumption. In a stoichiometry study of C. neoformans ADE2, which is a bifunctional
enzyme containing both PurE and PurK (thus both enzymes are locked into a 1:1 ratio), the
reaction was stoichiometric.14 However, N5-CAIR was also released from the enzyme.14
Studies on the E. coli PurK and PurE enzymes in a 1:1 ratio gave non-stoichiometric
consumption of ATP.14
In the pathway for the conversion of AIR to SAICAR, the concentration of N 5-CAIR
depends on the rate constants for PurK (k1), PurE (k2) and the decomposition rate k4
(Scheme 4.1). There are two factors that affect the reaction rate: the activity of the enzymes
and the quantity of enzymes in the reaction. In our stoichiometric studies, non-stoichiometry
happened when the molar ratio of PurE/PurK is 1:2. Although PurE is highly active, the
lower amount of PurE required a longer time to convert N5-CAIR to CAIR, which lead to
the decomposition to AIR and thus more ATP consumption. A PurE/PurK complex could
help to regulate these two enzymes in the pathway to prevent the wasteful decomposition of
N5-CAIR by tightly controlling its synthesis and use.

Scheme 4.1 Conversion of AIR to SAICAR.

Our studies have revealed that the use of N5-CAIR as an intermediate is not a problem as
long as the amount of monomer PurE and PurK are equal. The reason for this is unclear as it
may be due simply to kinetics or it could be due to the nature of the function of a complex
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between the PurE and PurK.
4.3 Is there evidence for a protein-protein interaction between PurE and PurK?
The challenge of N5-CAIR in the middle of the pathway could be dealt with by the
formation of a PurK and PurE complex in which each enzyme is regulated by the other. Our
studies have shown that the activities of either PurE or PurK are different when the other
enzyme is present. Such a result indicates that PurE and PurK may form a complex which
affects the kinetics of each enzyme.
An example of a protein-protein interaction that regulates a metabolic function is
imidazole glycerol phosphate (ImGP) synthase from T. maritima.24 ImGP synthase is a
necessary enzyme which links histidine and de novo purine biosynthesis.24 It is a
bifunctional enzyme complex, consisting of a glutaminase subunit (tHisH) and a synthase
subunit (tHisF). tHisH produces ammonia which reacts with the unstable substrate,
N’-((5’-phosphoribulosyl) formimino-5-aminoimidazole-4-ribo- nucleotide
(PRFAR)(Scheme 4.2).24 Results of association state assays showed that tHisH and tHisF
form a complex and enzyme kinetic assays for tHisF and the tHisH-tHisF complex showed
that the kinetic constants of tHisF were affected in the presence of tHisH.24 The quaternary
structure of the complex provided a hypothesis in which the protein-protein interaction
forms a hydrophobic channel facilitating the transfer of ammonia from tHisH to tHisF for
attack on PRFAR.
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Scheme 4.2 The reaction of ImGP synthase (tHisH-tHisF).
Another study on protein-protein interactions involving an unstable intermediate,
carbamoyl phosphate (CP), in hyperthermophile Pyrococcus furiosus also has been done.25
CP is produced by carbamoyl-phosphate synthetase (CKase) and is utilized by ornithine
carbamoyltransferase (OTCase). The t1/2 of CP is about 5 min at 37 °C26, while at 100 °C,
the optimal growth temperature of P. furious, the t1/2 is less than 2 s.25 The product of CP
decomposition is cyanate, whose accumulation is harmful to the bacteria. A channeling
cluster formed by CKase and OTCase was confirmed by two approaches including affinity
electrophoresis and co-immunoprecipitate techniques.25 This channeling for CP is
significant for the bacteria because it not only allows for an efficient reaction, but also
protects the cells from cyanate.
Organisms utilize dramatic approaches to overcome enormous challenges from both
internal and external environments. The mechanism of PurE and PurK enzymes from T.
maritima for dealing with the problem of the unstability of N5-CAIR is still not clear so far.
Our studies provide a hint that an enzyme complex is probably formed. More evidence is
required to confirm our hypothesis.
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5. Future Study
To confirm our hypothesis in which PurE and PurK from T. maritima form a complex to
stabilize N5-CAIR, techniques to determine a protein-protein interaction will be applied,
such as chemical cross-linking, gel filtration or chromatography. The complex can also be
determined by CD spectroscopy.
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De novo purine biosynthesis is divergent depending upon the organism. In bacteria, yeasts
and

plants,

5-aminoimidazole

4-carboxyaminoimidazole

ribonucleotide

ribonucleotide

(CAIR)

(AIR)
by

is

converted

to

N5-carboxyaminoimidazole

ribonucleotide (N5-CAIR) synthetase (PurK) and N5-CAIR mutase (Class I PurE). In
animals, AIR is converted into CAIR by AIR carboxylase (Class II PurE). The distinction
makes PurK and Class I PurE good targets in design of antimicrobial drugs. N5-CAIR is
chemically unstable with t1/2 of about 0.9 minutes at pH 7.8 and 37 °C. If the production of
N5-CAIR is not regulated relative to its conversion to CAIR, ATP utilization can rapidly
become non-stoichiometric. One mechanism to study this problem is to investigate how the
problem is dealt with under conditions in which N5-CAIR is even more unstable, such as at
higher temperature. Thermotoga maritima, originally isolated from geothermal heated
marine sediment, is a thermophilic bacterium whose optimal growth temperature is 80°C.
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The

TM0446

and

TM0447

genes

of

Thermotoga

maritima

encode

a

phosphoribosylaminoimidazole mutase (PurE) and synthetase (PurK) individually. We
cloned genes and expressed both proteins. Enzyme kinetic analyses for each enzyme
indicate that these enzymes follow the same pathway as those found in E. coli. Studies of
the stoichiometry of the reaction reveal that at elevated temperature, the reactions are
stoichiometric as long as the ratio of PurE and PurK is 1:1. When this ratio is lower, ATP
consumption becomes non-stoichiometric. We have also examined whether there is a
complex formed between these enzymes. Our data indicate that each enzyme is capable of
regulating the activity of the other. This suggests that a complex is formed by these two
enzymes.
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